Shareholder letter - Monday May 13, 2013
Link to document.
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
February 24, 2014
RegeneRx Receives Israeli Patent for Treatment of Dry Eye Syndrome
May 13, 2013
RegeneRx Issues Letter to Shareholders